Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1993 Oct;61(10):4240–4247. doi: 10.1128/iai.61.10.4240-4247.1993

Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed.

S Ansher 1, W Thompson 1, J Bridgewater 1, P Snoy 1
PMCID: PMC281150  PMID: 8406812

Abstract

Administration of pertussis toxin (PT) in combination with diphtheria and tetanus toxoids adsorbed (DT vaccine) or with acellular pertussis vaccine adsorbed and diphtheria and tetanus toxoids (APDT) elicits dose- and time-dependent alterations in hepatic drug metabolism in mice. Cytochrome P-450 (P-450) levels were inhibited more than 50% at 7 days following a single injection of PT mixed with either vaccine. When combined with DT vaccine, 125 ng of PT was required to produce this effect, while as little as 16 ng of PT combined with APDT vaccine inhibited P-450 levels. The inhibition of P-450 levels is similar to that observed after a single injection of diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP). Alterations of P-450 levels were accompanied by increased activities of quinone reductase but not with changes in plasma interleukin-6 or tumor necrosis factor levels. Other Bordetella pertussis virulence factors, such as filamentous hemagglutinin, fimbriae and pertactin, were also tested but had no significant effect on hepatic drug metabolism. Endotoxin or preparations containing endotoxin caused alterations in hepatic drug metabolism within 24 h, concomitant with increased interleukin-6 and tumor necrosis factor levels, but these effects had resolved by 1 week. DTP vaccine and preparations containing PT caused a marked induction of gamma interferon coincident with the maximal inhibition of P-450 levels. This effect was not present with DT or APDT vaccine alone, nor with endotoxin or any combination of factors that did not contain PT. These results demonstrate that PT is a necessary component for the sustained effects of DTP vaccine on hepatic drug metabolism and suggest a role for gamma interferon in this process.

Full text

PDF
4240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansher S. S., Puri R. K., Thompson W. C., Habig W. H. The effects of interleukin 2 and alpha-interferon administration on hepatic drug metabolism in mice. Cancer Res. 1992 Jan 15;52(2):262–266. [PubMed] [Google Scholar]
  2. Ansher S., Thompson W., Habig W. Vaccine-induced alterations in hepatic drug metabolism. Vaccine. 1991 Apr;9(4):277–283. doi: 10.1016/0264-410x(91)90112-j. [DOI] [PubMed] [Google Scholar]
  3. Ansher S., Thompson W., Snoy P., Habig W. Role of endotoxin in alterations of hepatic drug metabolism by diphtheria and tetanus toxoids and pertussis vaccine adsorbed. Infect Immun. 1992 Sep;60(9):3790–3798. doi: 10.1128/iai.60.9.3790-3798.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ashworth L. A., Robinson A., Irons L. I., Morgan C. P., Isaacs D. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Lancet. 1983 Oct 15;2(8355):878–881. doi: 10.1016/s0140-6736(83)90869-3. [DOI] [PubMed] [Google Scholar]
  5. Benson A. M., Hunkeler M. J., Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5216–5220. doi: 10.1073/pnas.77.9.5216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bertini R., Bianchi M., Erroi A., Villa P., Ghezzi P. Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J Leukoc Biol. 1989 Sep;46(3):254–262. doi: 10.1002/jlb.46.3.254. [DOI] [PubMed] [Google Scholar]
  7. Black W. J., Munoz J. J., Peacock M. G., Schad P. A., Cowell J. L., Burchall J. J., Lim M., Kent A., Steinman L., Falkow S. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science. 1988 Apr 29;240(4852):656–659. doi: 10.1126/science.2896387. [DOI] [PubMed] [Google Scholar]
  8. Calandra T., Gerain J., Heumann D., Baumgartner J. D., Glauser M. P. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med. 1991 Jul;91(1):23–29. doi: 10.1016/0002-9343(91)90069-a. [DOI] [PubMed] [Google Scholar]
  9. Cody C. L., Baraff L. J., Cherry J. D., Marcy S. M., Manclark C. R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981 Nov;68(5):650–660. [PubMed] [Google Scholar]
  10. Hannan S. E., May J. J., Pratt D. S., Richtsmeier W. J., Bertino J. S., Jr The effect of whole virus influenza vaccination on theophylline pharmacokinetics. Am Rev Respir Dis. 1988 Apr;137(4):903–906. doi: 10.1164/ajrccm/137.4.903. [DOI] [PubMed] [Google Scholar]
  11. Hochstein H. D., Elfin R. J., Cooper J. F., Seligmann E. B., Jr, Wolff S. M. Further developments of Limulus Amebocyte Lysate test. Bull Parenter Drug Assoc. 1973 May-Jun;27(3):139–148. [PubMed] [Google Scholar]
  12. Kramer P., McClain C. J. Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med. 1981 Nov 19;305(21):1262–1264. doi: 10.1056/NEJM198111193052106. [DOI] [PubMed] [Google Scholar]
  13. LeMay D. R., LeMay L. G., Kluger M. J., D'Alecy L. G. Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am J Physiol. 1990 Jul;259(1 Pt 2):R126–R132. doi: 10.1152/ajpregu.1990.259.1.R126. [DOI] [PubMed] [Google Scholar]
  14. Mannering G. J., Renton K. W., el Azhary R., Deloria L. B. Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems. Ann N Y Acad Sci. 1980;350:314–331. doi: 10.1111/j.1749-6632.1980.tb20631.x. [DOI] [PubMed] [Google Scholar]
  15. Miller D. L., Ross E. M., Alderslade R., Bellman M. H., Rawson N. S. Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) 1981 May 16;282(6276):1595–1599. doi: 10.1136/bmj.282.6276.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moxon E. R., Rappuoli R. Haemophilus influenzae infections and whooping cough. Lancet. 1990 Jun 2;335(8701):1324–1329. doi: 10.1016/0140-6736(90)91200-t. [DOI] [PubMed] [Google Scholar]
  17. Munoz J. J., Peacock M. G. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species. Microbiol Immunol. 1989;33(4):341–355. doi: 10.1111/j.1348-0421.1989.tb01982.x. [DOI] [PubMed] [Google Scholar]
  18. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  19. Okuno H., Takasu M., Kano H., Seki T., Shiozaki Y., Inoue K. Depression of drug-metabolizing activity in the human liver by interferon-beta. Hepatology. 1993 Jan;17(1):65–69. [PubMed] [Google Scholar]
  20. Peppoloni S., Nencioni L., Di Tommaso A., Tagliabue A., Parronchi P., Romagnani S., Rappuoli R., De Magistris M. T. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect Immun. 1991 Oct;59(10):3768–3773. doi: 10.1128/iai.59.10.3768-3773.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Renton K. W., Gray J. D., Hall R. I. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J. 1980 Aug 23;123(4):288–290. [PMC free article] [PubMed] [Google Scholar]
  22. Renton K. W., Mannering G. J. Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents. Biochem Biophys Res Commun. 1976 Nov 22;73(2):343–348. doi: 10.1016/0006-291x(76)90713-0. [DOI] [PubMed] [Google Scholar]
  23. Sidey F. M., Furman B. L., Wardlaw A. C. Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice. Vaccine. 1989 Jun;7(3):237–241. doi: 10.1016/0264-410x(89)90236-3. [DOI] [PubMed] [Google Scholar]
  24. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  25. Starnes H. F., Jr, Pearce M. K., Tewari A., Yim J. H., Zou J. C., Abrams J. S. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol. 1990 Dec 15;145(12):4185–4191. [PubMed] [Google Scholar]
  26. Zerkle T. B., Wade A. E. Depressant effects of the interferon inducer polyriboinosinic:polyribocytidylic acid on cytochrome P-450 hemoproteins. Pharmacology. 1984;28(1):1–11. doi: 10.1159/000137937. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES